Author:
de Lusignan S.,Belsey J.,Hague N.,Dhoul N.,van Vlymen J.
Publisher
Oxford University Press (OUP)
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference41 articles.
1. Department of Health. National Service Framework: Coronary Heart Disease. London 2000.http://www.dh.gov.uk/assetRoot/04/05/75/19/04057519.pdf (11July2006, date last accessed).
2. Department of Health. NHS Confederation and British Medical Association. Quality and Outcomes Framework (QOF) Guidance and Evidence Base.http://www.dh.gov.uk/assetRoot/04/08/86/93/04088693.pdf (11July2006, date last accessed).
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet1994;344:1383–9.
4. Sacks FM , Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med1996;335:1001–9.
5. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med1995;339:1349–57.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献